Understand device risk in its clinical environment
Connected medical device security requires a shared view of technology, manufacturer support, and clinical use. HIPAA CyberOps helps assess exposure and ownership without assuming that conventional IT testing is appropriate for patient-connected equipment. The service is scoped with clinical engineering and relevant operational stakeholders before any technical activity.
What the service covers
Establish inventory and lifecycle context
Review device identity, software information where available, network placement, remote support, responsible owners, and support status. Record uncertain information rather than treating an incomplete inventory as complete coverage.
Evaluate supported safeguards
Assess access restrictions, network boundaries, maintenance processes, and vendor-supported update options. Use documentation review or approved nonintrusive methods when active testing is unsuitable. Coordinate any proposed changes with clinical and manufacturer guidance.
Practical deliverables
Scope and deliverables are agreed before work begins. Depending on your environment, the engagement can include:
- A device-scope and ownership summary with inventory gaps.
- Prioritized exposure and lifecycle findings.
- Supported mitigation options and unresolved vendor questions.
- A validation and exception-review plan.
Can unsupported equipment be made risk-free through segmentation?
No. Segmentation can restrict particular communication paths, but its effectiveness depends on configuration, monitoring, and clinical requirements. Residual risk, maintenance limits, and replacement planning still need an accountable decision.
Related services
Discuss your healthcare security priorities
Describe your organization and clinical constraints at a high level. Do not send patient information, medical records, credentials, or incident evidence. Services do not provide official HIPAA certification or guarantee compliance.